{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:15:28Z","timestamp":1761185728884,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.parkreldis.2023.105863","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T11:20:35Z","timestamp":1695468035000},"page":"105863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploring the connection between Parkinson's disease and Sj\u00f6gren's syndrome: The aquaporin link"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-4535","authenticated-orcid":false,"given":"Pulukool","family":"Sandhya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debasish","family":"Danda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2023.105863_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2023.105863_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120014","article-title":"Parkinsonism in viral, paraneoplastic, and autoimmune diseases","volume":"433","author":"Xing","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2023.105863_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000333222","article-title":"Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden","volume":"10","author":"Li","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.parkreldis.2023.105863_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/07853890.2017.1412088","article-title":"Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan","volume":"50","author":"Chang","year":"2018","journal-title":"Ann. Med."},{"key":"10.1016\/j.parkreldis.2023.105863_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.999820","article-title":"Inflammatory rheumatic diseases and the risk of Parkinson's disease: a systematic review and meta-analysis","volume":"13","author":"He","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib7","article-title":"Risk of Parkinson disease in Sj\u00f6gren syndrome administered ineffective immunosuppressant therapies: a nationwide population-based study","volume":"98","author":"Ju","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.parkreldis.2023.105863_bib8","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s10067-020-05053-z","article-title":"Higher risk of Parkinson disease in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Hsu","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib9","article-title":"Impact of Sjogren's syndrome on Parkinson's disease: a nationwide case-control study","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2023.105863_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2022.1027044","article-title":"Risk of dementia or Parkinson's disease in the presence of Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2022","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.parkreldis.2023.105863_bib11","first-page":"14","article-title":"The association between Parkinson's disease and autoimmune diseases: a systematic review and meta-analysis","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib12","first-page":"2413","article-title":"Sj\u00f6gren syndrome study group, GEAS-SEMI, practical diagnostic tips for the Sj\u00f6gren clinic: pearls, myths and mistakes","volume":"40","author":"Brito-Zer\u00f3n","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib13","first-page":"1","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.parkreldis.2023.105863_bib14","first-page":"57","article-title":"[A case of Sj\u00f6gren\u2019s syndrome with a high titer of anticardiolipin antibody that developed as parkinsonism]","volume":"37","author":"Mochizuki","year":"1997","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.parkreldis.2023.105863_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10067-006-0398-8","article-title":"Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism","volume":"26","author":"Hassin-Baer","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","article-title":"Autoimmune disease and risk for Parkinson disease: a population-based case-control study","volume":"73","author":"Rugbjerg","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105863_bib17","article-title":"Inverse association of Parkinson disease with systemic lupus Erythematosus: a nationwide population-based study","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.parkreldis.2023.105863_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3233\/JPD-202418","article-title":"Decreased risk of Parkinson's disease after rheumatoid arthritis diagnosis: a nested case-control study with matched cases and controls","volume":"11","author":"Bacelis","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2023.105863_bib19","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000013303","article-title":"Disease-modifying antirheumatic drugs and risk of Parkinson disease: nested case-control study of people with rheumatoid arthritis","volume":"98","author":"Paakinaho","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105863_bib20","article-title":"EULAR-SS task force big data consortium, influence of geolocation and ethnicity on the phenotypic expression of primary Sj\u00f6gren\u2019s syndrome at diagnosis in 8310 patients: a cross-sectional study from the big data Sj\u00f6gren project consortium","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.parkreldis.2023.105863_bib21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/1756-185X.13201","article-title":"Primary Sj\u00f6gren\u2019s syndrome in Asia: Yin and Yang?","volume":"20","author":"Sandhya","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.parkreldis.2023.105863_bib22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"System Genomics of Parkinson's Disease Consortium, International Parkinson's Disease Genomics Consortium, Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib23","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3233\/JPD-223176","article-title":"Immunogenetic determinants of Parkinson's disease etiology","volume":"12","author":"Kung","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2023.105863_bib24","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3233\/JPD-223240","article-title":"New perspectives on immune involvement in Parkinson's disease pathogenesis","volume":"12","author":"Gate","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2023.105863_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162717","article-title":"Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant","volume":"11","author":"Hoenen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2023.105863_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/NEN.0b013e3181b66f1b","article-title":"Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression","volume":"68","author":"Song","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib27","doi-asserted-by":"crossref","first-page":"a020628","DOI":"10.1101\/cshperspect.a020628","article-title":"Astrocytes in neurodegenerative disease","volume":"7","author":"Phatnani","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2019.00303","article-title":"Autoimmunity in Parkinson's disease: the role of \u03b1-synuclein-specific T cells","volume":"10","author":"Garretti","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136768","article-title":"Novel inflammasome and oxidative modulators in Parkinson's disease: a prospective study","volume":"786","author":"Roy","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2023.105863_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fneur.2018.00815","article-title":"A systematic review and meta-analysis of alpha synuclein auto-antibodies in Parkinson's disease","volume":"9","author":"Scott","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib31","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/1756-185X.13641","article-title":"Determinants of diagnosis and disease course in primary Sj\u00f6gren\u2019s syndrome: results from datamining of electronic health records","volume":"22","author":"Sandhya","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.parkreldis.2023.105863_bib32","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00415-020-10377-6","article-title":"Impact of comorbid Sj\u00f6gren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders","volume":"268","author":"Akaishi","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104466","article-title":"A novel association of osmotic demyelination in Sj\u00f6gren\u2019s syndrome prompts revisiting role of aquaporins in CNS demyelinating diseases: a literature review","volume":"69","author":"Sandhya","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2023.105863_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/ijms18010055","article-title":"Aquaporins in brain edema and neuropathological conditions","volume":"18","author":"Filippidis","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.parkreldis.2023.105863_bib35","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.3390\/ijms19113392","article-title":"Involvement of aquaporins in the pathogenesis, diagnosis and treatment of Sj\u00f6gren\u2019s syndrome","volume":"19","author":"Soyfoo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.parkreldis.2023.105863_bib36","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12026-016-8786-x","article-title":"Detection of autoantibodies against aquaporin-5 in the sera of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"64","author":"Alam","year":"2016","journal-title":"Immunol. Res."},{"key":"10.1016\/j.parkreldis.2023.105863_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-329389","article-title":"Risk of Parkinson's disease in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide cohort study in South Korea","author":"Kwon","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2023.105863_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/brain\/awab311","article-title":"Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis","volume":"145","author":"Salman","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2023.105863_bib39","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3390\/biomedicines10092261","article-title":"The role of glymphatic system in alzheimer's and Parkinson's disease pathogenesis","volume":"10","author":"Buccellato","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.parkreldis.2023.105863_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11064-011-0637-5","article-title":"Peripheral assessment of the genes AQP4, PBP and TH in patients with Parkinson's disease","volume":"37","author":"Thenral","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.parkreldis.2023.105863_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bpa.12369","article-title":"Expression of aquaporin 1 and aquaporin 4 in the temporal neocortex of patients with Parkinson's disease","volume":"27","author":"Hoshi","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.parkreldis.2023.105863_bib42","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1007\/s12031-021-01836-4","article-title":"Decreased AQP4 expression aggravates \u0251-synuclein pathology in Parkinson's disease mice, possibly via impaired glymphatic clearance","volume":"71","author":"Cui","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.parkreldis.2023.105863_bib43","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.neurobiolaging.2007.02.015","article-title":"Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine and astrocytic modulation","volume":"29","author":"Fan","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2023.105863_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuroscience.2016.01.003","article-title":"Aquaporin-4 mediates communication between astrocyte and microglia: implications of neuroinflammation in experimental Parkinson's disease","volume":"317","author":"Sun","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2023.105863_bib45","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1111\/jcmm.14147","article-title":"Aquaporin-4 deficiency reduces TGF-\u03b21 in mouse midbrains and exacerbates pathology in experimental Parkinson's disease","volume":"23","author":"Xue","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.parkreldis.2023.105863_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2015.12.057","article-title":"Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease","volume":"614","author":"Zhang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2023.105863_bib47","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1474-9726.2011.00677.x","article-title":"Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease","volume":"10","author":"Chi","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.parkreldis.2023.105863_bib48","article-title":"Aquaporin-4 polymorphisms are associated with cognitive performance in Parkinson's disease","volume":"13","author":"Fang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2023.105863_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/glia.23528","article-title":"Loss of perivascular aquaporin-4 in idiopathic normal pressure hydrocephalus","volume":"67","author":"Hasan-Olive","year":"2019","journal-title":"Glia"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:28:50Z","timestamp":1761179330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802023009422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":49,"alternative-id":["S1353802023009422"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105863","relation":{},"ISSN":["1353-8020"],"issn-type":[{"type":"print","value":"1353-8020"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the connection between Parkinson's disease and Sj\u00f6gren's syndrome: The aquaporin link","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105863"}}